Strong Full-Year Financial Performance
FY2025 consolidated revenue of $947.7M, up $252.5M or 36.3% year-over-year; adjusted EBITDA of $72.5M, up $19.2M or 36%; adjusted EBITDA prior to NCI $76.7M, up $21.6M or 39.2%; full-year adjusted EPS $1.18, exceeding the midpoint of updated guidance ($1.16).
Robust Fourth Quarter Home Health & Hospice Growth
Q4 Home Health & Hospice revenue of $233.3M, up $91.3M or 64.3% YoY; Q4 adjusted EBITDA $33.7M, up $12.4M or 58.2%; Q4 admissions surged 81.3% and Medicare admissions grew 87.5% YoY; same-store Medicare admissions +8.2% and Medicare revenue per episode +3.7% YoY.
High Clinical Quality Metrics
Average CMS home health star rating rose to 4.2 (national average 3.0); hospice CMS quality composite score 97.5%; Columbia River example: CMS star 4.5, potentially preventable hospitalizations 6.2% vs national 10.8%.
Accelerating Hospice Performance
Hospice average daily census of 5,060 in Q4, up 46.9% YoY; same-store hospice ADC +8.4%, admissions +6.6%, and hospice Medicare revenue per day +5.9% YoY.
Senior Living Momentum
FY2025 Senior Living revenue $215M, up $39.2M or 22.3% YoY; Q4 revenue $56.1M, up 19.6% YoY; Q4 Senior Living adjusted EBITDA $6.1M, up $1.9M or 46%; all-store occupancy up 200 bps to 80.6%, same-store occupancy up 250 bps to 82.1%, RevPOR +5.6% YoY.
Strategic M&A Execution and Scale Expansion
Completed Signature Healthcare at Home integration (Jan 1, 2025) and closed largest acquisition in history—over 50 locations from UnitedHealth and Amedisys (Oct 2025); opportunistic senior living operations and real estate acquisitions (two senior living deals closed in Q4).
Conservative, Growth-Oriented 2026 Guidance
2026 guidance: revenue $1.13B–$1.17B (midpoint +22.4%), adjusted EBITDA $88.5M–$94.1M (midpoint +26%), adjusted EBITDA prior to NCI $94.2M–$100M (midpoint +26.7%), adjusted EPS $1.26–$1.36 (midpoint $1.31); guidance reflects anticipated ramp and integration timing.
Healthy Balance Sheet and Cash Flow Outlook
Expanded credit facility with $100M term loan to total $350M; invested $147.2M in UnitedHealth acquisition; net debt/adjusted EBITDA 1.7x (well under 3.25x covenant); Q4 operating cash flow $21M, FY YTD $48.3M; forecasted operating cash flow for 2026 $45M–$55M and CapEx ~ $15M.